Reden O 2 mg/150 mg Tablet
By Reden O
Rx
10 Tablet in a Strip

Composition
Ondansetron(2mg) + Ranitidine(150mg)

Manufacturer - Medoz Pharmaceutical Pvt. Ltd
Sco-83, 1st Flr, Swastik Vihar Mansa Devi Complex, Sec-5, Panchkula (HRY)-134114

Expires on or after
October, 2025

liver
When using Reden O 2 mg/150 mg Tablet, caution should be taken in individuals with liver disease. It may be necessary to adjust the dosage of the medication in such cases. It is advisable to consult your doctor for guidance on the proper use of Reden O 2 mg/150 mg Tablet in relation to liver issues.

kidney
Reden O 2 mg/150 mg Tablet requires caution in patients with kidney disease. Dosage adjustment might be necessary. Consult your doctor for proper guidance.

alcohol
It is unsafe to drink alcohol while taking Reden O 2 mg/150 mg Tablet. Avoid alcohol consumption to prevent potential risks.

driving
Reden O 2 mg/150 mg Tablet typically does not impact driving ability. It is generally safe to drive while taking this medication.

pregnancy
Reden O 2 mg/150 mg Tablet is generally safe to use during pregnancy based on animal studies with low adverse effects. Limited human studies are available, so it is advisable to consult your doctor before using.

breastfeeding
Reden O 2 mg/150 mg Tablet is considered safe to use while breastfeeding. The available limited human data indicates no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹42.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025